Hexavalent recombinant norovirus vaccine (Hansenula Polymorpha,Yuanda Weixin)
六价重组诺如病毒疫苗（汉逊酵母，远大赛威信）
Report date: 2025/12/18 20:00:07
Base Information
Drug NameHexavalent recombinant norovirus vaccine (Hansenula Polymorpha,Yuanda Weixin)
Drug Alias NameN/A
Classification +[5]
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesYuanda Weixin Life Science (Nanjing) Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesFar contest Weixin Life Science (Hangzhou) Co LtdYuanda Weixin Life Science (Nanjing) Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A